Novo Nordisk
-
World
How Viking Therapeutics is poised to disrupt pharma
Shares of Viking Therapeutics (VKTX) are rising after data from the company’s latest weight loss drug trial showed greater efficacy…
Read More »
Senators grilled Novo Nordisk CEO Lars Jørgensen Tuesday at a hearing over the costs of Ozempic, Wegovy and similar weight…
Read More »Shares of Viking Therapeutics (VKTX) are rising after data from the company’s latest weight loss drug trial showed greater efficacy…
Read More »